Bruker Co. (NASDAQ:BRKR) has received an average recommendation of "Hold" from the thirteen brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $64.64.
A number of equities research analysts have weighed in on BRKR shares. BTIG Research raised their price objective on Bruker from $73.00 to $80.00 and gave the company a "buy" rating in a research note on Thursday, May 6th. SVB Leerink raised their price objective on Bruker from $80.00 to $85.00 and gave the company an "outperform" rating in a research note on Friday, June 18th. Zacks Investment Research lowered Bruker from a "buy" rating to a "hold" rating and set a $73.00 price objective for the company. in a research note on Wednesday, June 9th. Finally, Cleveland Research upgraded Bruker from a "neutral" rating to a "buy" rating and set a $75.00 target price for the company in a research report on Tuesday, June 15th.
Shares of BRKR stock traded up $0.85 during trading hours on Wednesday, reaching $73.87. The company had a trading volume of 2,940 shares, compared to its average volume of 565,488. Bruker has a twelve month low of $36.82 and a twelve month high of $75.82. The company's fifty day simple moving average is $69.57. The company has a quick ratio of 1.32, a current ratio of 2.06 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $11.19 billion, a P/E ratio of 55.37, a P/E/G ratio of 2.06 and a beta of 1.30.
Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Tuesday, May 4th. The medical research company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.32 by $0.12. Bruker had a return on equity of 26.44% and a net margin of 9.63%. The firm had revenue of $554.70 million during the quarter, compared to analyst estimates of $506.56 million. During the same quarter last year, the firm earned $0.14 EPS. Bruker's quarterly revenue was up 30.8% on a year-over-year basis. Research analysts forecast that Bruker will post 1.86 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, June 18th. Investors of record on Tuesday, June 1st were issued a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.22%. The ex-dividend date was Friday, May 28th. Bruker's dividend payout ratio (DPR) is 11.85%.
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Sowell Financial Services LLC lifted its holdings in shares of Bruker by 74.2% in the 1st quarter. Sowell Financial Services LLC now owns 399 shares of the medical research company's stock worth $27,000 after purchasing an additional 170 shares during the last quarter. Parallel Advisors LLC lifted its holdings in shares of Bruker by 138.4% in the 1st quarter. Parallel Advisors LLC now owns 441 shares of the medical research company's stock worth $28,000 after purchasing an additional 256 shares during the last quarter. NEXT Financial Group Inc lifted its holdings in shares of Bruker by 128.4% in the 1st quarter. NEXT Financial Group Inc now owns 450 shares of the medical research company's stock worth $29,000 after purchasing an additional 253 shares during the last quarter. Fifth Third Bancorp lifted its holdings in shares of Bruker by 438.9% in the 1st quarter. Fifth Third Bancorp now owns 485 shares of the medical research company's stock worth $31,000 after purchasing an additional 395 shares during the last quarter. Finally, Inspire Advisors LLC bought a new stake in shares of Bruker in the 4th quarter worth approximately $28,000. 69.30% of the stock is currently owned by institutional investors and hedge funds.
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
Further Reading: Understanding the different types of bonds
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured Article: What is a Buy-Side Analyst?7 Great Dividend Stocks to Buy For a Comfortable Retirement
There are people who will say the day of set it and forget it retirement accounts are over. But it’s a narrative we’ve heard before. The truth is the formula for saving for and enjoying a comfortable retirement, like the formula for weight loss, hasn’t really changed. A lot depends on whether an individual has the discipline to see it through.
Dividend stocks remain one of the core elements of a retirement portfolio. As individuals near retirement the ability to reinvest dividends allows for a greater total return. And once individuals need to live off their portfolio, the dividends provide a source of income without having to tap their principal.
However, not all dividend stocks are the same and many investors get sucked in by the allure of a high-yield dividend stock. But what you’re really looking for are companies with a history of increasing its dividend. The ability to increase a dividend over time illustrates that the company has a business model that can hold up regardless of how the broader economy is performing.
In this special presentation, we’ll highlight seven stocks that individuals can buy today to capture a stable, recurring dividend.
View the "7 Great Dividend Stocks to Buy For a Comfortable Retirement"